View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Tyson Foods To Participate in 19th Annual BMO Global Farm to Market Co...

Tyson Foods To Participate in 19th Annual BMO Global Farm to Market Conference SPRINGDALE, Ark., May 02, 2024 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (NYSE: TSN) announced today that management will participate in the 19th Annual BMO Global Farm to Market Conference on May 15, 2024 in New York City. The fireside chat with Donnie King, president & CEO, and John R. Tyson, executive vice president & CFO, will begin at approximately 8:00 a.m. Eastern Time and will be available via a live webcast. The webcast link, replay, and other information can be accessed on the company’s investor relations...

 PRESS RELEASE

CSX Executive Vice President and Chief Commercial Officer to Address B...

CSX Executive Vice President and Chief Commercial Officer to Address Bank of America Transportation, Airlines and Industrials Conference JACKSONVILLE, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) Executive Vice President and Chief Commercial Officer, Kevin Boone, will address the Bank of America Transportation, Airlines and Industrials Conference in New York on Tuesday, May 14, at 8:00 a.m. Eastern time.  This address will be broadcast live via webcast at . A replay will be available following the conclusion of this event. This announcement, as well as additional financ...

 PRESS RELEASE

Philip Morris International to Present at 2024 Jefferies Virtual Reduc...

STAMFORD, CT--(BUSINESS WIRE)-- Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will present at the 2024 Jefferies Virtual Reduced Risk Seminar on May 7, 2024. “The Science of Smoke-Free Products & Nicotine” will be presented by Gizelle Baker, VP Global Scientific Engagement, at 09:00 a.m. ET. “Leading & Transforming Through Innovation in Smoke-Free Products” will be presented by Stefano Volpetti, President Smoke-Free Inhalable Products & Chief Consumer Officer, at 11:00 a.m. ET. The webcast of the presentations will be available at . The slides and archived recordings...

ASML Holding N.V.: Update following change of outlook to positive

Our credit view of this issuer reflects its strong track record of innovation.

 PRESS RELEASE

Philip Morris International to Host Webcast of 2024 Virtual Annual Mee...

STAMFORD, CT--(BUSINESS WIRE)-- Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast of its 2024 Annual Meeting of Shareholders on Wednesday, May 8, 2024, at 9:00 a.m. ET. The meeting will be held in a virtual format only and can be accessed at . Presentation slides, script and an archived recording of the webcast will be available at the same link. The recording will be available for approximately one year from the date of the meeting. During the meeting, André Calantzopoulos, Executive Chairman of the Board, and Jacek Olczak, Chief Executive O...

Wedbush Research
  • Wedbush Research
2454 MEDIATEK INC.
LOGN LOGITECH INTERNATIONAL S.A.
VMW VMWARE INC. CLASS A
QRVO QORVO INC.
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SGMO SANGAMO THERAPEUTICS INC.
SBUX STARBUCKS CORPORATION
RWT REDWOOD TRUST INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
PCRX PACIRA BIOSCIENCES INC.
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
MCD MCDONALD'S CORPORATION
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
FTNT FORTINET INC.
FATE FATE THERAPEUTICS INC
EXLS EXLSERVICE HOLDINGS INC.
EAT BRINKER INTERNATIONAL INC.
DENN DENNY'S CORPORATION
CTMX CYTOMX THERAPEUTICS INC.
CMRX CHIMERIX INC
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
AXTI AXT INC.
ARDX ARDELYX INC
SWKS SKYWORKS SOLUTIONS INC.
FRX_CN FENNEC PHARMACEUTICALS
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
TMHC TAYLOR MORRISON HOME CORPORATION
HPE HEWLETT PACKARD ENTERPRISE CO.
TWTR TWITTER INC.
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
AVGO BROADCOM INC.
HEAR TURTLE BEACH CORP.
SURF SURFACE ONCOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
AX AXOS FINANCIAL INC.
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
PINS PINTEREST INC. CLASS A
BCEL ATRECA
DELL DELL TECHNOLOGIES INC CLASS C
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
LC LENDINGCLUB CORP
SMCI SUPER MICRO COMPUTER
AQST INC.
IDYA AQUESTIVE THERAPEUTICS
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
CRSR ADICET BIO INC
ITOS CORSAIR GAMING
ZNTL ITEOS THERAPEUTICS
PRAX ZENTALIS PHARMACEUTICALS
FUBO PRAXIS PRECISION MEDICINES
TVTX FUBOTV
LSEA TRAVERE THERAPEUTICS INC
VRDN LANDSEA HOMES CORP (A)
DAWN VIRIDIAN THERAPEUTICS INC
ELEV DAY ONE BIOPHARMACEUTICALS INC
OMGA ELEVATION ONCOLOGY
LBPH OMEGA THERAPEUTICS
THRX LONGBOARD PHARMACEUTICALS
MRVL THESEUS PHARMACEUTICALS
STX INC.
DSGN MARVELL TECHNOLOGY INC
ATXS SEAGATE TECHNOLOGY HLDGS PLC
AVTE DESIGN THERAPEUTICS INC
GFS ASTRIA THERAPEUTICS INC
RLYB AEROVATE THERAPEUTICS INC
KRTX GLOBALFOUNDRIES INC
FUSN RALLYBIO CORP
VIGL KARUNA THERAPEUTICS INC
EWTX FUSION PHARMACEUTICALS INC
VIGIL NEUROSCIENCE INC
EDGEWISE THERAPEUTICS INC

Meta Platforms, Inc.: Update to Credit Analysis Following Upgrade to A...

Our credit view of Meta reflects the company's leading market position, exceptional liquidity, very strong credit metrics, and profitability offset by material legal and regulatory risks

International Business Machines Corporation: Update following change i...

Our credit view of this issuer reflects its good track record for divesting non-strategic business lines, offset by its mature demand for remaining legacy offerings.

Dan Salmon
  • Dan Salmon

GOOGL/AMZN/META: How much are they spending on AI Capex (v2.3)?

We remain above 2024 consensus for each of GOOGL (9% higher), AMZN (11%) and META (13%). For 2025-2027, we are at least 8% ahead of consensus for each, including 27% ahead for META in 2025.

Dan Salmon
  • Dan Salmon

GOOGL 1Q24 Model Update: Raising target to $200 from $185 on higher ma...

Our target price increases to $200 from $185 on higher estimates. Investment Thesis: Sentiment on GOOGL continues to improve markedly, as the new dividend, solid topline results and strong margins more than compensated for higher capex.

Dan Salmon
  • Dan Salmon

META 1Q24 Model Update: Target declines to $580 from $600 on higher ca...

Our target price declines to $580 from $600 on lower estimates. Investment Thesis: META may be in the penalty box for a few quarters as consensus estimates come in, and catalysts get more likely going into September events (Connect, Conversations). We remain Buy rated and would build positions near-term, then accumulate more aggressively as catalysts approach.

Philip Morris International Inc: 1 director

A director at Philip Morris International Inc sold 20,000 shares at 96.420USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...

Novartis AG: 1 director

A director at Novartis AG sold 55,000 shares at 90.477CHF and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch